Zacks10d agobearish
IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent shares down 13% despite revenue growth.
Noticias
Solo titulares de alta señal — eventos macro, earnings, M&A, regulación. Listicles y clickbait de analistas filtrados por defecto. Refrescado cada hora.
173last 24h
1624last 7d
287🟢 bullish (7d)
174🔴 bearish (7d)
138publishers
Zacks13d agobearish
Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue EstimatesUltragenyx (RARE) delivered earnings and revenue surprises of -18.96% and -15.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
